Literature DB >> 30165437

2018 ESC/EACTS Guidelines on myocardial revascularization.

Franz-Josef Neumann, Miguel Sousa-Uva, Anders Ahlsson, Fernando Alfonso, Adrian P Banning, Umberto Benedetto, Robert A Byrne, Jean-Philippe Collet, Volkmar Falk, Stuart J Head, Peter Jüni, Adnan Kastrati, Akos Koller, Steen D Kristensen, Josef Niebauer, Dimitrios J Richter, Petar M Seferovic, Dirk Sibbing, Giulio G Stefanini, Stephan Windecker, Rashmi Yadav, Michael O Zembala.   

Abstract

Year:  2019        PMID: 30165437     DOI: 10.1093/eurheartj/ehy394

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  970 in total

Review 1.  Perioperative planning for cardiovascular operations in the COVID-19 pandemic.

Authors:  Hayrettin Levent Mavioğlu; Ertekin Utku Ünal; Göktan Aşkın; Şeref Alp Küçüker; Mehmet Ali Özatik
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2020-04-03       Impact factor: 0.332

Review 2.  The Role of Fractional Flow Reserve and Instantaneous Wave-Free Ratio Measurements in Patients with Acute Coronary Syndrome.

Authors:  Abdul Rahman Ihdayhid; Jin-Sin Koh; John Ramzy; Arnav Kumar; Michael Michail; Adam Brown; Habib Samady
Journal:  Curr Cardiol Rep       Date:  2019-11-25       Impact factor: 2.931

3.  Inflammatory Conditions in Acute Coronary Syndrome Patients Treated with Percutaneous Coronary Intervention of Saphenous Vein Graft.

Authors:  Tayyar Cankurt; İbrahim E Celik; Selcuk Ozturk; Orhan Maden
Journal:  Int J Angiol       Date:  2020-08-30

4.  Successful extracorporeal membrane oxygenation assisted revascularisation in a high-risk elderly patient refused surgical treatment.

Authors:  Robertas Samalavičius; Lina Puodžiukaitė; Vytautas Abraitis; Ieva Norkienė; Nadežda Ščupakova; Justina Pekarskienė; Aleksejus Zorinas; Kęstutis Ručinskas; Pranas Šerpytis
Journal:  Acta Med Litu       Date:  2019

5.  Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention: The SMART-CHOICE Randomized Clinical Trial.

Authors:  Joo-Yong Hahn; Young Bin Song; Ju-Hyeon Oh; Woo Jung Chun; Yong Hawn Park; Woo Jin Jang; Eul-Soon Im; Jin-Ok Jeong; Byung Ryul Cho; Seok Kyu Oh; Kyeong Ho Yun; Deok-Kyu Cho; Jong-Young Lee; Young-Youp Koh; Jang-Whan Bae; Jae Woong Choi; Wang Soo Lee; Hyuck Jun Yoon; Seung Uk Lee; Jang Hyun Cho; Woong Gil Choi; Seung-Woon Rha; Joo Myung Lee; Taek Kyu Park; Jeong Hoon Yang; Jin-Ho Choi; Seung-Hyuck Choi; Sang Hoon Lee; Hyeon-Cheol Gwon
Journal:  JAMA       Date:  2019-06-25       Impact factor: 56.272

Review 6.  Physiologic Assessment of Coronary Stenosis: Current Status and Future Directions.

Authors:  Sercan Okutucu; Mehmet Cilingiroglu; Marc D Feldman
Journal:  Curr Cardiol Rep       Date:  2021-06-03       Impact factor: 2.931

Review 7.  Multimodality imaging for the prevention of cardiovascular events: Coronary artery calcium and beyond.

Authors:  Duygu Kocyigit; Alexandra Scanameo; Bo Xu
Journal:  Cardiovasc Diagn Ther       Date:  2021-06

8.  Manual versus mechanical compression hemostasis approach after coronary angiography via snuffbox access.

Authors:  Farshad Roghani-Dehkordi; Elham Zangeneh; Mohammad Kermani-Alghoraishi
Journal:  Anatol J Cardiol       Date:  2021-03       Impact factor: 1.596

Review 9.  [ESC/EACTS guidelines on myocardial revascularization 2018 : The most important innovations].

Authors:  F-J Neumann; W Hochholzer; M Siepe
Journal:  Herz       Date:  2018-12       Impact factor: 1.443

10.  Facilitation Through Aggrastat or Cangrelor Bolus and Infusion Over PrasugreL: a MUlticenter Randomized Open-label Trial in PatientS with ST-elevation Myocardial InFarction Referred for PrimAry PercutaneouS InTERvention (FABOLUS FASTER) Trial: Design and Rationale : The FABOLUS FASTER Trial.

Authors:  Giuseppe Gargiulo; Giovanni Esposito; Plinio Cirillo; Michael Nagler; Pietro Minuz; Gianluca Campo; Felice Gragnano; Negar Manavifar; Raffaele Piccolo; Marisa Avvedimento; Matteo Tebaldi; Andreas Wahl; Lukas Hunziker; Michael Billinger; Dik Heg; Stephan Windecker; Marco Valgimigli
Journal:  J Cardiovasc Transl Res       Date:  2020-02-24       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.